Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Millendo Therapeutics Announces Data Presentation for Nevanimibe at ENDO 2018

Millendo Therapeutics,Inc.
Posted on: 07 Mar 18

Millendo Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for endocrine diseases, today announced that data from its nevanimibe (ATR-101) program will be presented in an oral presentation at The Endocrine Society’s (ENDO) 100th Annual Meeting and Expo, being held March 17-20, 2018 in Chicago, Illinois. The presentation will contain a discussion of clinical results from a Phase 2 proof-of-concept study of nevanimibe in classic congenital adrenal hyperplasia (CAH), a rare inherited endocrine disease characterized by abnormal hormone levels and overgrowth of the adrenal glands.

Details of the oral presentation are as follows:

Title: A Phase 2, Multicenter Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia
Oral Session Number: OR19
Session Name: Adrenal Insufficiency and Adrenal Tumor
Date/ Time: Monday, March 19, 2018, 12:15 – 12:30 PM CDT
Location: McCormick Place West, Room W187

About Millendo Therapeutics, Inc.

Millendo Therapeutics is focused on developing novel treatments for endocrine diseases. Our mission is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of diseases where there is a significant unmet medical need. We are currently advancing livoletide for the treatment of Prader-Willi Syndrome (PWS) and nevanimibe for the treatment of classic congenital adrenal hyperplasia and endogenous Cushing’s syndrome. www.millendo.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20180307005166/en/

Business Wire
www.businesswire.com

Last updated on: 07/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.